Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.22
+0.11009.91%
Post-market: 1.230.0100+0.82%19:58 EDT
Volume:2.69M
Turnover:3.16M
Market Cap:125.66M
PE:-1.18
High:1.24
Open:1.14
Low:1.13
Close:1.11
52wk High:2.72
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:1.03
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:28.75
PE(LYR):-0.67

Loading ...

Inovio Pharmaceuticals Inc. Stock Advances 8.1%, Outperforms Peers

Dow Jones
·
May 22

Inovio partner ApolloBio says VGX-3100 Phase 3 cervical dysplasia trial hits endpoint

Reuters
·
May 22

Positive Topline Results From a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by Apollobio, Inovio's Partner in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - VGX-3100 Phase 3 Trial Meets Primary Endpoint With Favorable Safety Profile

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals Inc - Apollobio to Pursue Regulatory Submission for VGX-3100 in China

THOMSON REUTERS
·
May 22

Inovio Pharmaceuticals held annual shareholder meeting, investors elected eight directors

Reuters
·
May 21

Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze

TIPRANKS
·
May 20

Inovio Pharmaceuticals Inc. Stock Slides 6.2%, Underperforms Peers

Dow Jones
·
May 19

Inovio Pharmaceuticals Earnings Call: Progress Amid Cash Strain

TIPRANKS
·
May 15

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 15

Inovio Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

BRIEF-Inovio Reports First Quarter 2026 Financial Results And Recent Business Highlights

Reuters
·
May 14

Inovio Pharmaceuticals posts flat Q1 net loss

Reuters
·
May 14

Inovio Pharmaceuticals Q1 EPS USD -0.28

THOMSON REUTERS
·
May 14

Inovio Pharmaceuticals Q1 EPS $(0.28) Beats $(0.36) Estimate, Sales $0.000 Miss $250.000K Estimate

Benzinga Earnings
·
May 14

Inovio Pharmaceuticals Inc - FDA Actively Reviewing Ino-3107 Bla Under Accelerated Approval With Pdufa Date Oct 30, 2026

THOMSON REUTERS
·
May 14

Inovio Pharmaceuticals Inc - Anticipates Cash Will Fund Operations Into Q1 2027, Beyond Pdufa Date

THOMSON REUTERS
·
May 14

Inovio options imply 15.1% move in share price post-earnings

TIPRANKS
·
May 14

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 13

Inovio Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview

Reuters
·
May 12